跳至主要内容
临床试验/ACTRN12615000296538
ACTRN12615000296538招募中未知

In children and adolescents, is assessment of ADHD using the novel EfA system as effective and sensitive as other known methods in reaching a high quality and accurate diagnosis?

Dr. Yariv Doron0 个研究点目标入组 200 人开始时间: 2015年3月31日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Diagnosis
盲法
Open (masking not used)

入排标准

年龄范围
6 Years 至 18 Years(—)
性别
All

入选标准

  • * Age 6-18 years
  • * Referred query ADHD
  • * Both the client and his/her parent/legal guardian have given their consent (when applicable)
  • * Both the client and the legal guardian are cognitively able to give an informed consent

排除标准

  • * Known intellectual impairment
  • * Known major neurological disorder (such as: Epilepsy, CNS disease, head trauma, CP, etc)
  • * Sensory impairment (deafness, blindness)
  • * Other major mental health diagnosis (Psychosis, Major depression, Severe anxiety/OCD, etc)

研究者

发起方
Dr. Yariv Doron

相似试验